Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol 30, iss 10 Cancer Epidemiol Biomarkers Prev. Roel, E, Pistillo, A, Recalde, M, Sena, A G, Fernández-Bertolín, S, Aragón, M, Puente, D, Ahmed, W U R, Alghoul, H, Alser, O, Alshammari, T M, Areia, C, Blacketer, C, Carter, W, Casajust, P, Culhane, A C, Dawoud, D, DeFalco, F, DuVall, S L, Falconer, T, Golozar, A, Gong, M, Hester, L, Hripcsak, G, Tan, E H, Jeon, H, Jonnagaddala, J, Lai, L Y H, Lynch, K E, Matheny, M E, Morales, D R, Natarajan, K, Nyberg, F, Ostropolets, A, Posada, J D, Prats-Uribe, A, Reich, C G, Rivera, D R, Schilling, L M, Soerjomataram, I, Shah, K, Shah, N H, Shen, Y, Spotniz, M, Subbian, V, Suchard, M A, Trama, A, Zhang, L, Zhang, Y, Ryan, P B, Prieto-Alhambra, D, Kostka, K & Duarte-Salles, T 2021, ' Characteristics and outcomes of over 300,000 patients with COVID-19 and history of cancer in the United States and Spain ', Cancer Epidemiology Biomarkers and Prevention, vol. 30, no. 10, pp. 1884-1894 . https://doi.org/10.1158/1055-9965.EPI-21-0266 Cancer Epidemiology Biomarkers and Prevention, 30(10), 1884-1894. American Association for Cancer Research Inc.